当前位置: 首页 > 详情页

Potential of unilateral combined bypass surgery to accelerate contralateral radiological progression in pediatric moyamoya disease

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China [2]China International Neuroscience Institute (ChinaINI), Beijing, China [3]Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China [4]Department of Radiology and Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China [5]Department of Interventional Neuroradiology, Xuanwu Hospital, Capital Medical University, Beijing, China [6]Institute of Cerebrovascular Disease Research, Xuanwu Hospital, Capital Medical University, Beijing, China
出处:
ISSN:

关键词: Pediatric moyamoya disease (MMD) rapid progression combined bypass surgery non-operated progression (non-OP progression)

摘要:
Background: Surgical cerebral revascularization is recommended for treating pediatric moyamoya disease (MMD). However, whether unilateral combined bypass surgery can cause disease progression on the contralateral side is uncertain. The study aimed to investigate the vascular architecture and regional cerebral blood flow (rCBF) status of patients with pediatric MMD after successful unilateral combined bypass surgery and to identify the possible risk factors. Methods: Pediatric patients diagnosed with MMD and admitted to Xuanwu Hospital who underwent combined bypass surgery between 2019 and 2021 were enrolled. Digital subtraction angiography (DSA) and magnetic resonance imaging (MRI) with arterial spin labeling (ASL) were performed to investigate the vascular architecture and rCBF during surgery and at short-term follow-up. Suzuki's angiographic staging and moyamoya vessel grading system were both used. Progression was defined as an increase in either Suzuki stage or moyamoya vessel grade detected after unilateral surgery. All analyses were performed with conventional statistic methods. Results: A total of 27 successive patients with a median age of 8 [interquartile range (IQR), 5-14] years old were identified. On the non-operated (non-OP) side, 11 (40.7%) patients demonstrated progression, all of whom showed an increase in the moyamoya vessel grade, and 5 also displayed Suzuki stage progression during the median 4.7 (IQR, 3.7-5.7) months follow-up. However, rCBF barely changed on the non-OP side compared to preoperation (preoperation: median, 49.6, IQR, 42.9-61.1 mL/100 g/min; postoperation: median, 50.2, IQR, 43.5-59.3 mL/100 g/min; P=0.445). Conclusions: Combined bypass surgery might accelerate the radiological progression on the contralateral side, which occurs before the decline of rCBF. Those with earlier Suzuki stage MMD of the non-OP side are prone to rapid progression after unilateral combined revascularization.

基金:

基金编号: Z201100005520019 2020-2-1032

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类 | 3 区 医学
小类 | 3 区 核医学
最新[2023]版:
大类 | 2 区 医学
小类 | 3 区 核医学
JCR分区:
出版当年[2021]版:
Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
最新[2023]版:
Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

影响因子: 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者:
第一作者机构: [1]Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China [2]China International Neuroscience Institute (ChinaINI), Beijing, China
共同第一作者:
通讯作者:
通讯机构: [1]Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China [2]China International Neuroscience Institute (ChinaINI), Beijing, China [6]Institute of Cerebrovascular Disease Research, Xuanwu Hospital, Capital Medical University, Beijing, China [*1]Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, No. 45 Changchun Street, Xicheng District, Beijing 100053, China.China International Neuroscience Institute (China-INI), Beijing, China [*2]Institute of Cerebrovascular Disease Research, Xuanwu Hospital, Capital Medical University, No. 45 Changchun Street, Xicheng District, Beijing 100053, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院